NCT00547417

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

An Open-Label Study to Evaluate the Efficacy and Safety of Tadalafil Administered "On Demand" to Men of Various Populations With Erectile Dysfunction

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,933 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To compare men of different races and those with diabetes or depression to white men that do not have diabetes or depression but also suffer from the inability to get or keep an erection.

Conditions

• Impotence

Interventions

Type	Name	Description
DRUG	tadalafil	20 mg tadalafil tablet taken by mouth, as needed, no more than once a day, for 12 weeks.

Timeline

• Start date: 2003-07-01
• Completion: 2004-03-01
• First posted: 2007-10-22
• Last updated: 2007-10-22

Locations

1 site across 1 country: United States